Intraventricular haemorrhage, Papile grade 3/4 · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate probably leads to lower severe intraventricular haemorrhage (grade 3 or 4) (newborn/infant)** compared with placebo (outcomes (moderate certainty).
1 finding from 1 review
Bronchopulmonary dysplasia/chronic lung disease · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in chronic lung disease/bronchopulmonary dysplasia (newborn/infant)** compared with placebo (outcomes (low certainty).
1 finding from 1 review
Death (fetal, neonatal, or later (up to school age))** · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death (fetal, neonatal, or later (up to school age))** compared with placebo (outcomes (low certainty).
1 finding from 1 review
Intervention not reported
Good neurological outcome · adults after cardiopulmonary resuscitation
The intervention may leads to higher good neurological outcome (low certainty).
1 finding from 1 review
Intervention not reported
Survival · adults after cardiopulmonary resuscitation
The intervention showed no clear difference in survival (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events – pneumonia · adults after cardiopulmonary resuscitation
The intervention showed no clear difference in adverse events – pneumonia (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events – hypokalaemia · adults after cardiopulmonary resuscitation
It is very uncertain whether the intervention changes adverse events – hypokalaemia (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events – arrhythmia · adults after cardiopulmonary resuscitation
The intervention may leads to higher adverse events – arrhythmia (low certainty).
1 finding from 1 review
Survival to hospital discharge with good neurological function · patients with out‐of‐hospital cardiac arrest
1 finding from 1 review
Adverse events ‐ re‐arrest after randomization · patients with out‐of‐hospital cardiac arrest
It is very uncertain whether pre‐hospital cooling changes adverse events ‐ re‐arrest after randomization compared with in‐hospital cooling (very low certainty).
1 finding from 1 review